STRIKE - Treating Patients With Early Axial Spondyloarthritis to Target - a 1 Year Randomized Controlled Study Taking an Intense Treatment Approach Versus Routine Treatment

Trial Profile

STRIKE - Treating Patients With Early Axial Spondyloarthritis to Target - a 1 Year Randomized Controlled Study Taking an Intense Treatment Approach Versus Routine Treatment

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 27 Nov 2017

At a glance

  • Drugs Adalimumab (Primary)
  • Indications Ankylosing spondylitis; Spondylarthritis
  • Focus Therapeutic Use
  • Acronyms STRIKE
  • Sponsors AbbVie
  • Most Recent Events

    • 05 Nov 2017 Planned End Date changed from 10 Apr 2020 to 31 Jan 2018.
    • 05 Nov 2017 Planned primary completion date changed from 13 Sep 2019 to 31 Jan 2018.
    • 05 Nov 2017 Status changed from recruiting to active, no longer recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top